ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,754 | -21.2% | 35,320 | -4.7% | 0.00% | – |
| Q2 2023 | $490,674 | +42.5% | 37,060 | +46.5% | 0.00% | – |
| Q1 2023 | $344,333 | -39.0% | 25,300 | -12.5% | 0.00% | – |
| Q4 2022 | $564,847 | -59.2% | 28,922 | -60.3% | 0.00% | -100.0% |
| Q3 2022 | $1,386,000 | -89.3% | 72,779 | -88.5% | 0.00% | -83.3% |
| Q2 2022 | $13,001,000 | -63.8% | 631,118 | -43.5% | 0.01% | -57.1% |
| Q1 2022 | $35,956,000 | -40.8% | 1,117,346 | -14.4% | 0.01% | -33.3% |
| Q4 2021 | $60,771,000 | +68.6% | 1,305,213 | -2.2% | 0.02% | +50.0% |
| Q3 2021 | $36,047,000 | +3.7% | 1,335,081 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $34,758,000 | -13.1% | 1,355,078 | +15.8% | 0.01% | -22.2% |
| Q1 2021 | $39,991,000 | +7.7% | 1,170,001 | +6.5% | 0.02% | 0.0% |
| Q4 2020 | $37,138,000 | +96.0% | 1,098,100 | +43.0% | 0.02% | +80.0% |
| Q3 2020 | $18,949,000 | – | 768,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |